Anissa Abi-Dargham Selected Research

Anissa Abi-Dargham Research Topics

Disease

68	Schizophrenia (Dementia Praecox) 02/2024 - 05/2002
11	Psychotic Disorders (Schizoaffective Disorder) 02/2024 - 06/2002
5	Alcoholism (Alcohol Abuse) 01/2018 - 11/2005
5	Cognitive Dysfunction 01/2015 - 10/2003
4	Mental Disorders (Mental Disorder) 06/2023 - 03/2005
4	Schizotypal Personality Disorder 09/2020 - 05/2004
3	Hallucinations (Hallucination) 12/2019 - 01/2011
3	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 11/2011 - 12/2003
3	Social Phobia 01/2009 - 12/2002
2	Substance-Related Disorders (Drug Abuse) 06/2023 - 07/2012
2	Autism Spectrum Disorder 06/2023 - 12/2011
2	Anxiety Disorders (Anxiety Disorder) 06/2023 - 12/2002
2	Cocaine-Related Disorders (Cocaine Addiction) 11/2020 - 06/2009
2	Major Depressive Disorder (Major Depressive Disorders) 01/2020 - 10/2018
2	Heroin Dependence (Heroin Abuse) 07/2014 - 04/2012
1	Chronic Disease (Chronic Diseases) 07/2023
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 06/2023
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2023
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 02/2023
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Cerebral Cortical Thinning 01/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2019
1	Anhedonia 10/2018
1	Dizziness (Lightheadedness) 01/2015
1	Tachycardia (Tachyarrhythmias) 01/2015
1	Hypotension (Low Blood Pressure) 01/2015
1	Marijuana Abuse (Cannabis Abuse) 07/2014
1	Bulimia Nervosa 07/2012
1	Asperger Syndrome (Asperger's Syndrome) 12/2011

Drug/Important Bio-Agent (IBA)

57	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 09/2003
16	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 06/2002
9	Glutamic Acid (Glutamate)FDA Link 07/2023 - 11/2003
9	Serotonin (5 Hydroxytryptamine)IBA 01/2022 - 12/2002
9	Amphetamine (Amfetamine)FDA LinkGeneric 01/2021 - 03/2004
4	Cholinergic Agents (Cholinergics)IBA 02/2024 - 12/2006
4	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2021 - 05/2002
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2020 - 06/2005
4	gamma-Aminobutyric Acid (GABA)IBA 11/2015 - 01/2010
3	Biomarkers (Surrogate Marker)IBA 06/2023 - 10/2016
3	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2022 - 12/2008
3	Protons (Proton)IBA 01/2019 - 05/2012
3	dihydrexidineIBA 01/2016 - 01/2011
3	Cocaine (Cocaine HCl)IBA 07/2014 - 06/2009
3	5-HT1A Serotonin ReceptorIBA 06/2011 - 12/2006
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2005 - 11/2003
3	N-Methylaspartate (NMDA)IBA 09/2005 - 11/2003
3	NNC 112IBA 10/2003 - 05/2002
2	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 02/2023 - 06/2005
2	Therapeutic UsesIBA 01/2022 - 01/2007
2	Dynorphins (Dynorphin)IBA 01/2021 - 10/2019
2	naxagolideIBA 01/2021 - 10/2018
2	Naltrexone (ReVia)FDA LinkGeneric 10/2020 - 10/2019
2	Narcotic Antagonists (Opioid Antagonists)IBA 10/2020 - 10/2019
2	Naloxone (Narcan)FDA LinkGeneric 10/2020 - 10/2019
2	Dopamine D3 ReceptorsIBA 02/2020 - 10/2016
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2020 - 01/2015
2	Antidepressive Agents (Antidepressants)IBA 01/2020 - 10/2018
2	SCH 23390IBA 07/2013 - 09/2003
2	volinanserinIBA 12/2011 - 11/2011
2	5-HT2A Serotonin Receptor (5 HT2A Receptor)IBA 12/2011 - 11/2011
2	N- (2- (4- (2- methoxyphenyl)- 1- piperazinyl)ethyl)- N- (2- pyridinyl)cyclohexanecarboxamideIBA 06/2011 - 12/2006
2	fallyprideIBA 10/2010 - 12/2008
2	Neurotransmitter Agents (Neurotransmitter)IBA 10/2010 - 01/2010
2	McN 5652IBA 12/2003 - 12/2002
1	Acetylcholine (Acetylcholine Chloride)FDA Link 02/2024
1	Vesicular Acetylcholine Transport Proteins (Vesicular Acetylcholine Transporter)IBA 02/2024
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2022
1	pimavanserinIBA 01/2022
1	Trace Amine-Associated ReceptorsIBA 01/2022
1	SEP-363856IBA 01/2022
1	Serotonin 5-HT2 Receptor AgonistsIBA 01/2022
1	xanomelineIBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Dihydroxyphenylalanine (Dopa)IBA 01/2021
1	Methylphenidate (Ritalin)FDA LinkGeneric 01/2021
1	neuromelaninIBA 11/2020
1	Opioid Analgesics (Opioids)IBA 10/2020
1	nalmefene (Revex)FDA Link 10/2020
1	Buprenorphine (Subutex)FDA LinkGeneric 10/2020
1	dopamine D3 receptor antagonist F17464IBA 02/2020
1	brexpiprazoleIBA 01/2020
1	Levodopa (L Dopa)FDA LinkGeneric 01/2020
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 10/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2019
1	Pramipexole (Mirapex)FDA LinkGeneric 10/2018
1	RacloprideIBA 01/2018
1	N 30IBA 10/2016
1	LigandsIBA 10/2016
1	cariprazineIBA 10/2016
1	Risperidone (Risperdal Consta)FDA LinkGeneric 10/2015
1	CarbonIBA 04/2015
1	Saline SolutionIBA 01/2015
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2015
1	ParvalbuminsIBA 05/2012
1	Aminobutyrates (Aminobutyric Acid)IBA 05/2012
1	Glutamine (L-Glutamine)FDA Link 05/2012
1	ziprasidone (Geodon)FDA Link 06/2011
1	alpha-Methyltyrosine (Metirosine)FDA Link 06/2009

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2021